IVZ
30
-9
MDT
50
-3
MU
48
-4
MCHP
37
-5
DD
33
-4
STZ
55
-2
CINF
51
-3
FIS
72
-5
EIX
42
2
PLD
28
-4
DFS
47
-3
HSY
35
-2
FOXA
63
-3
AVGO
13
-2
DVA
59
-4
BRK.B
43
-6
MCD
57
-5
RL
59
-4
CMS
55
2
TGT
40
-4
IVZ
30
-9
MDT
50
-3
MU
48
-4
MCHP
37
-5
DD
33
-4
STZ
55
-2
CINF
51
-3
FIS
72
-5
EIX
42
2
PLD
28
-4
DFS
47
-3
HSY
35
-2
FOXA
63
-3
AVGO
13
-2
DVA
59
-4
BRK.B
43
-6
MCD
57
-5
RL
59
-4
CMS
55
2
TGT
40
-4
Financhill
Back

Office Properties Income Trust Vs. Royalty Pharma PLC Industry Stock Comparison

Sell
6

OPI
Office Properties Income Trust

Last Price:
$0.48
Seasonality Move:
-1.03%
Sell
28

RPRX
Royalty Pharma PLC

Last Price:
$31.38
Seasonality Move:
-2.74%
Sell
6
Office Properties Income Trust (OPI) is a Sell

Is Office Properties Income Trust a Buy, Sell or Hold?

  • The current Office Properties Income Trust [OPI] share price is $0.48. The Score for OPI is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
  • OPI is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
28
Royalty Pharma PLC (RPRX) is a Sell

Is Royalty Pharma PLC a Buy, Sell or Hold?

  • The current Royalty Pharma PLC [RPRX] share price is $31.37. The Score for RPRX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • RPRX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

OPI Stock Price Chart

What is Office Properties Income Trust's stock price today?

  • The Office Properties Income Trust share price today is $0.48
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OPI is experiencing slight selling pressure.

RPRX Stock Price Chart

What is Royalty Pharma PLC's stock price today?

  • The Royalty Pharma PLC share price today is $31.37
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RPRX is experiencing slight selling pressure.

OPI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 24.19 Sell
Chaikin Money Flow: -230434 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.61 - 0.93) Sell
Bollinger Bands (100): (0.77 - 1.35) Sell

RPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 35.44 Sell
Chaikin Money Flow: -282065 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.41 - 33.81) Sell
Bollinger Bands (100): (26.01 - 32.63) Buy

OPI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.56 Sell
20-day SMA: 0.74 Sell
50-day SMA: 0.85 Sell
200-day SMA: 1.63 Sell
8-day EMA: 0.57 Sell
20-day EMA: 0.69 Sell
50-day EMA: 0.85 Sell
200-day EMA: 1.72 Sell

RPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 32.84 Sell
20-day SMA: 32.99 Sell
50-day SMA: 32.42 Sell
200-day SMA: 28.45 Buy
8-day EMA: 32.44 Sell
20-day EMA: 32.75 Sell
50-day EMA: 31.89 Sell
200-day EMA: 29.45 Buy

Office Properties Income Trust Earnings Growth & OPI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $0.51 per share.

Royalty Pharma PLC Earnings Growth & RPRX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.18 per share, an increase this year of $0.62 per share, and an increase next year of $0.31 per share.

Office Properties Income Trust Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Royalty Pharma PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):